(For treatment side effects and complications only)
Posted 6th February 2024
NHS Providers, the national body that represents NHS health and care providers, has featured Cheshire and Merseyside's community diagnostic centres (CDCs) in a new case study. It looks at how Paddington CDC - which is owned and run by The Clatterbridge Cancer Centre NHS Foundation Trust on behalf of the NHS in our region - was established. (Read the NHS Providers case study.)
Paddington CDC opened in July 2023 and provides CT, MRI and ultrasound scans for patients referred by their GP for tests at hospitals across Cheshire and Merseyside. It also does blood tests for people being treated by The Clatterbridge Cancer Centre.
Community diagnostic centres (CDCs) were set up to offer people quicker, easier access to vital heath tests and scans outside of busy acute hospitals.
Cheshire and Merseyside has been at the forefront of developing the new centres, with 10 across the region. The rollout has been a key priority for Cheshire and Merseyside Diagnostics Programme, which is part of a wider programme of work by Cheshire and Merseyside Acute and Specialist Trusts (CMAST).
The Clatterbridge Cancer Centre's Chief Executive, Liz Bishop, is senior responsible officer for Cheshire and Merseyside Diagnostics Programme.
Read the NHS Providers case study.